8-KEarnings & ResultsExhibits & Filings

GILEAD SCIENCES, INC. 8-K Report, Financial Results (Oct 28, 2020)

Filed October 28, 2020For Securities:GILD

Summary

Gilead Sciences, Inc. (GILD) filed an 8-K on October 28, 2020, to report its financial results for the quarter ended September 30, 2020. The filing primarily directs investors to the accompanying press release (Exhibit 99.1) for detailed financial information, including both GAAP and non-GAAP metrics. Management believes non-GAAP measures offer useful insights for investors for operational and planning purposes, though they are not a substitute for GAAP-reported results and may differ from industry peers. Investors are encouraged to review the reconciliation provided in the press release for a comprehensive understanding of the financial performance. The core purpose of this 8-K is to formally disclose the third-quarter financial performance. While the 8-K itself is brief, the attached press release contains the substance of Gilead's operational and financial condition for the period. Investors should focus on the financial data and management commentary within Exhibit 99.1 to assess the company's performance, revenue drivers, profitability, and outlook.

Key Highlights

  • 1Gilead Sciences announced its financial results for the quarter ended September 30, 2020, via an 8-K filing on October 28, 2020.
  • 2The filing includes a press release (Exhibit 99.1) containing detailed financial information.
  • 3Both GAAP and non-GAAP financial measures are presented.
  • 4Management considers non-GAAP financial information useful for internal operational, budgeting, and financial planning purposes.
  • 5Investors are advised that non-GAAP measures may be defined and calculated differently by other companies.
  • 6A reconciliation between GAAP and non-GAAP financial information is available on pages 14-16 of the press release.
  • 7The information provided is not deemed 'filed' for Section 18 of the Exchange Act.

Frequently Asked Questions

The detailed financial results, including both GAAP and non-GAAP measures, are provided in the press release filed as Exhibit 99.1 to this 8-K filing.

Gilead's management uses non-GAAP financial information internally for operational, budgeting, and financial planning. They believe it can be useful to investors when viewed alongside GAAP financial statements, offering an additional perspective on the company's performance.

No, investors should use non-GAAP measures only to supplement their understanding of Gilead's operating results as reported under GAAP. Non-GAAP information is not prepared under comprehensive accounting rules and may be calculated differently by other companies. A reconciliation between GAAP and non-GAAP figures is provided in the press release.

The information in this Form 8-K and its exhibits are not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934, nor are they incorporated by reference into other filings, unless specifically stated otherwise within a particular filing.